Stay updated on ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial page.

Latest updates to the ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial page
- Check3 days agoChange DetectedThe ClinicalTrials.gov record for the azenosertib ovarian cancer study appears unchanged.SummaryDifference0.0%

- Check10 days agoChange DetectedThe page now displays the ClinicalTrials.gov record for the ovarian cancer study, including its design, eligibility criteria, locations, and study dates, instead of a 403 error.SummaryDifference81%

- Check17 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0; the study record remains unavailable with a 403 Forbidden error.SummaryDifference0.2%

- Check24 days agoChange DetectedA general NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” appears at the top of the page, while the previous 403 error screen is no longer shown. The study details are not visible.SummaryDifference2%

- Check31 days agoChange DetectedThe footer’s ClinicalTrials.gov revision changed from v3.7.1 to v3.7.2. The page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check38 days agoChange DetectedThe ClinicalTrials.gov footer revision updates from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

Stay in the know with updates to ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial page.